ICE-T Conference presenters explain what nurses and APPs should take into account as immune cell effector therapies become ...

Hope S. Rugo, MD, FASCO, emphasized the importance of educating patients about proactive rash and diarrhea management while taking PI3K/AKT inhibitors.

Panelists discuss City of Hope’s multidisciplinary approach, highlighting pharmacists providing medication guidance, social ...

Panelists share that despite initial emotional challenges, multiple myeloma treatment with targeted combination therapies was ...

Establishing routine early on helps proactively manage adverse effects associated with CDK4/6 inhibitors, says Kimberly ...

Panelists discuss the critical role of patient education and multidisciplinary coordination in managing immunotherapy side ...

Panelists discuss the importance of vigilant, patient-centered monitoring for metastatic melanoma patients with high disease ...

A generic version of ibrutinib was granted tentative approval by the FDA for use in CLL and SLL with 17p deletion and Waldenström macroglobulinemia.

Paolo Tarantino, MD, PhD, explains that the chemotherapy-related toxicities from an ADC are more likely to limit dosage for ...